Skip to content

CT Indexes of Emphysema and Airways in Healthy Volunteers: Normal Values; Relations With Gender, Height and Weight

CT Indexes of Emphysema and Airways in Healthy Volunteers: Normal Values; Relations With Gender, Height and Weight

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02611947
Enrollment
87
Registered
2015-11-23
Start date
2010-10-31
Completion date
2011-06-30
Last updated
2015-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

emphysema, airway remodelling, multidetector computed tomography

Brief summary

Various indexes have been proposed to quantify both pulmonary emphysema and airways disease on chest CT scans. It is unknown whether these indexes should be consider in absolute values or as compared to predicted normal values. The purposes of the present study is thus : a) to measure these indexes at CT in healthy volunteers; b) to investigate their relations with gender, height and weight.

Detailed description

87 healthy volunteers performed consecutively a low-dose chest CT scan and pulmonary function tests: 1. On chest CT scans, indexes reflecting pulmonary emphysema and airways measurements have been computed by using dedicated softwares. Each of our three readers performed two reading sessions. Relative area of lung parenchyma with attenuation value less than -960 Hounsfield Units; luminal area and wall thickness in third and fourth generations airways were recorded. 2. Pulmonary function tests were performed: vital capacity, forced vital capacity , functional residual capacity, total lung capacity, residual volume, forced expiratory volume in one second, and diffusion lung capacity for carbon monoxide were recorded (either in absolute values and percentage of predicted values). CT indexes were compared with gender, height and weight.

Interventions

RADIATIONLow-dose chest CT scans

Supine chest CT scan after full inspiration. Acquisition parameters: (Topogram 35 mA 120 kV 512 mm length) 35 quality ref mAs with care-dose ON 120 kV Pitch 1.4 Rotation time 0.33 s Acquired images 64 x 0.6 mm

Sponsors

Erasme University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Never smoked. * No respiratory infection in the 4 weeks before the begin of the study. * No history of pulmonary resection. * No active malignancy or malignancy of any organ system within the past 5 years.

Exclusion criteria

* no

Design outcomes

Primary

MeasureTime frameDescription
CT index - RA960 (%)4 hoursFrom acquired data, images were reconstructed using a soft algorithm. On these soft images, the relative area of lung parenchyma with attenuation value less than -960 Hounsfield Units was computed (expressed in %), as an index representative of pulmonary emphysema extent.
CT index - LA3rd (mm2)4 hoursFrom acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway lumen was measured in third generations of airways (expressed in mm2).
CT index - LA4th (mm2)4 hoursFrom acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway lumen was measured in fourth generations of airways (expressed in mm2).
CT index - WT3rd (mm)4 hoursFrom acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway wall was measured in third generations of airways (expressed in mm).
CT index - WT4th (mm)4 hoursFrom acquired data, images were reconstructed using a high resolution algorithm. On these high-resolution images, the airway wall was measured in fourth generations of airways (expressed in mm).

Secondary

MeasureTime frameDescription
Pulmonary function tests - FEV1 (l)4 hoursForced expiratory volume in one second was measured (expressed in l).
Pulmonary function tests - VC (l)4 hoursVital capacity was measured (expressed in l).
Pulmonary function tests - DLCO (ml/min/ mmHg)4 hoursDiffusion lung capacity for carbon monoxide was measured (expressed in ml/min/ mmHg)
Pulmonary function tests - FVC (l)4 hoursForced vital capacity was measured (expressed in l).
Pulmonary function tests - FRC (l)4 hoursFunctional residual capacity capacity was measured (expressed in l).
Pulmonary function tests - TLC (l)4 hoursTotal lung capacity was measured (expressed in l).
Pulmonary function tests - RV (l)4 hoursResidual volume was measured (expressed in l).

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026